Infection and Adverse Pregnancy Outcome
NCT02673216 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2200
Last updated 2021-05-10
Summary
Miscarriage (spontaneous abortion, stillbirth, and preterm birth) is the most common adverse out-come of pregnancy and a significant proportion is caused by infection. The investigators aim to study vaginal specimens from 1200 pregnant women recruited before 14 weeks of gestation with follow-up at mid-term (week 19) as well as 300 women aborting spontaneously. Adverse pregnancy outcome will be correlated to the presence of bacterial vaginosis (BV) subclasses, to vaginal fluid inflammation markers, and to the presence of novel Chlamydia-like bacteria, in particular Waddlia chondrophila. Species specific quantitative PCR assays for BV-related bacteria as well as next-generation-sequencing will be applied on selected specimens with the aim to identify markers allowing for a personalised treatment approach.
Conditions
Interventions
- OTHER
-
No intervention
Sponsors & Collaborators
-
Aarhus University Hospital Skejby
collaborator OTHER -
Statens Serum Institut
lead OTHER
Principal Investigators
-
Jorgen S Jensen, DMedSci, PhD · Statens Serum Institut
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2020-12-31
- Completion
- 2023-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Technical Feasibility of the cfDNA Test for Non-invasive Cytogenetic Analysis of Early Miscarriages Versus the Gold Standard Microarray
NCT05900076 ·Status: COMPLETED
-
Venous Thromboembolism in Pregnancy Study
NCT00856076 ·Status: UNKNOWN
-
Maternal Use of Antibiotics and the Risk of Congenital Malformations
NCT06770465 ·Status: ACTIVE_NOT_RECRUITING
-
The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage
NCT01916928 ·Status: COMPLETED
-
Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
NCT04232189 ·Status: TERMINATED
-
Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome
NCT06918236 ·Status: RECRUITING
-
Comprehensive Assessment of Risks for Miscarriage.
NCT04456660 ·Status: RECRUITING
-
Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy
NCT06802874 ·Status: RECRUITING
-
Fetal Growth and Pregnancy Complications Among Women With Heart Disease
NCT03657823 ·Status: UNKNOWN
-
Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF
NCT03122704 ·Status: WITHDRAWN ·Phase: NA
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors
NCT05557201 ·Status: RECRUITING
-
Cell Based Non Invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling Following Preimplantation Genetic Testing
NCT04584047 ·Status: COMPLETED ·Phase: NA
-
Maternal and Fetal/Neonatal Pharmacokinetics and - Dynamics of Corticosteroids During Pregnancy
NCT06264973 ·Status: RECRUITING
-
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
NCT04718220 ·Status: COMPLETED ·Phase: NA
-
Pregnancy Loss Between 15 and 22 Weeks SA Within the Network of Perinatal Pérriodof Western Brittany : Case Control Study PILOT STUDY CA
NCT03668743 ·Status: COMPLETED
-
First Trimester of Pregnancy: Impact of a History of Miscarriage on Women's Stress
NCT04841486 ·Status: COMPLETED
-
SARS-COV-2 VARIANTS' EFFECT ON PREGNANCY AND LONG-TERM OUTCOMES AMONG PREGNANT WOMEN AND THEIR NEWBORNS IN ESTONIA
NCT06806696 ·Status: COMPLETED
-
Obstetric and Perinatal Outcomes of Women With COVID-19
NCT04369859 ·Status: COMPLETED
-
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
NCT05186779 ·Status: TERMINATED
-
Motherhood and Microbiome
NCT02030106 ·Status: COMPLETED
-
The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase(MTHFR) Gene Polymorphisms as Risk Factors for Recurrent Miscarriage
NCT03209063 ·Status: UNKNOWN
-
Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
NCT05625724 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of a Patient Blood Management Protocol Impact on the Transfusion Rate in Delivery Hemorrhage
NCT06916832 ·Status: COMPLETED
-
Non-invasive Monitoring of Miscarriage
NCT06581692 ·Status: RECRUITING